Ingrid Wiik and Lars Thunell were elected as new members of Statoil's (OSE: STL; NYSE: STO) board of directors by the corporate assembly on 22 June.
Ingrid Wiik (60) is president and CEO of Alpharma in New York. She has held various managerial posts in Apothekernes Laboratorium/Alpharma, and has been CEO in the USA since 2000. Ms Wiik is a director of Coloplast in Denmark and Norske Skog in Norway.
Lars Thunell (56) is chief executive of SE-Banken, Stockholm. He was deputy managing director of ABB before becoming deputy chief executive of Nordbanken, chief executive of Securum and chief executive of Trygg-Hansa until its merger with SE-Banken. Mr Thunell is a director of Akzo Nobel (Sweden), the Swedish Bankers' Association and B-business partners (Sweden).
Eli Sætersmoen withdraws from the board with effect from 22 June.